Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
BrH/c1-17(2
3-d]pyrimidin-2-yl}amino)pyridin-3-yl]piperazin-1-yl}methyl)-1H-1
YM-58483 (1-30 mg/kg
ventilated OA-sensitive guinea pigs
InChi: InChI=1S/C18H13ClFN3
Efaproxiral sodium ahydrozoline Hydrochloride BrH/c1-17(2Efaproxiral sodium (RSR13 sodium) is a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy. in vitro: Efaproxiral increases oxygen levels in hypoxic tumor tissues by binding non covalently to the hemoglobin tetramer and decreasing hemoglobin oxygen binding affinity. Increasing tumor oxygenation reduces tumor radioresistance. Efaproxiral can